Form 4: Axon Enterprise Director Jeri Williams Sells Shares Under 10b5-1 Trading Plan

Director Jeri Williams sold 220 shares of Axon Enterprise, Inc. common stock at a price of $375.94 per share on August 22, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• On August 22, 2024, Jeri Williams, a director of Axon Enterprise, Inc., sold 220 shares of common stock.
• The sale was executed at a price of $375.94 per share.
• Following the transaction, Williams directly owns 2,044 shares of Axon Enterprise, Inc.
• The sale was conducted under a Rule 10b5-1 trading plan adopted on May 23, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports a routine stock sale under a pre-arranged trading plan. There is no indication of positive or negative implications for the company.

Industry Context

Sales by insiders are a normal part of corporate governance. The use of a 10b5-1 plan suggests the sale was pre-planned and not based on any specific inside information.

Comparison to Industry Standards

• Insider sales are common across publicly traded companies, especially by directors and officers.
• The use of a 10b5-1 trading plan is a standard practice to avoid accusations of insider trading, similar to practices at companies like Motorola Solutions and Digital Ally, which also operate in related sectors.

Stakeholder Impact

• The sale of shares by a director could have a minor psychological impact on shareholders, but the use of a 10b5-1 plan mitigates concerns about insider information.

Key Dates